UTHR

UTHR options carry 42.7K contracts of open interest across 7 expiries, 88% of it in the Oct 16 contract, with 0.89 puts per call.

12% of open interest sits beyond the Oct 16 contract · 29 strikes listed for it · 42.7K contracts open in all

The Oct 16 contract holds 19K calls and 18.4K puts, the most call OI at $540.00 and the most put OI at $460.00; max pain $510.00, −5.9% from the close.

Call OI, contracts

19K18,990 contracts

Put OI, contracts

18.4K18,353 contracts

Puts per call, by OI

0.97all expiries 0.89

Max pain

$510.00−5.9% from the close

Strikes listed

29for this expiry

Revenue $783.3M, −1.9% on a year earlier; profit $333.0M, +7.6% in the Jun 2026 quarter, consolidated.

UTHR trades at 19 times trailing earnings against 20 for its industry, 3.6 times book value, revenue +2.5% over twelve months, market cap $23.24B.

Market cap

$23.24Bon Sep 30

Price to earnings

19consolidated · four quarters to Jun 2026 · industry 20

Trailing EPS

$27.91diluted · consolidated · four quarters to Jun 2026

Price to book

3.6consolidated · balance sheet to Jun 2026

Book value a share

$149.22consolidated · balance sheet to Jun 2026

Debt to equity

—

Return on equity

19%trailing profit over average equity · consolidated

Dividend yield

—

Price to sales

7.4market cap over revenue, four quarters to Jun 2026

Shares outstanding

42.9Mon Sep 30

Revenue, trailing 12 months

$3.15Bfour quarters to Jun 2026

Revenue growth, 12 months

▲ +2.5%against the twelve months before

Revenue 3-year CAGR

▲ +14%trailing twelve months against the twelve months 3 years earlier · consolidated

Profit, trailing 12 months

$1.31Bfour quarters to Jun 2026

Profit growth, 12 months

▲ +5.5%against the twelve months before

Profit 3-year CAGR

▲ +15%trailing twelve months against the twelve months 3 years earlier · consolidated

13F managers hold 190% of shares, BlackRock, Inc. the largest at 25%, Avoro Capital Advisors LLC 13% and VANGUARD PORTFOLIO MANAGEMENT LLC 8.9%, as filed for the quarter to Jun 2026.

• BlackRock, Inc. 24.7%
• Avoro Capital Advisors LLC 12.9%
• VANGUARD PORTFOLIO MANAGEMENT LLC 8.9%
• Other 13F managers 138.9%

Held by 13F managers

190%of shares outstanding

Shares held

79.5M−1.3% on Mar 2026 among managers filing both

Managers holding

819796 a quarter earlier

Largest holder

25%BlackRock, Inc.

No open-market insider buying or selling in the last 90 days.

No corporate action on record for UTHR yet.

UTHR is +5.7% over 20 sessions against the S&P 500's +0.1%, 11% below its 52-week high, realised volatility 50% annualised.

Average true range, 14

$173.1% of the close

Average day's range, 20

$193.4% of the close

Volume against 20 sessions

4.44×3.34M vs 895K average

Realised volatility, 20

50%≈ ±3.2% a session · moved more than that on 3 of 20

Realised volatility, 60

34%≈ ±2.1% a session · moved more than that on 8 of 60

Beta to S&P 500, 60

-0.22moved with S&P 500 on 29 of 60 sessions

Last 20 sessions

7 up · 13 downof 20

Last 60 sessions

23 up · 37 downof 60

Best session, 250

▲ +13%Sep 30

Worst session, 250

▼ −4.6%May 7

Short sales were 69% of reported volume on Sep 30, 2026, against 56% over the last 25 sessions.

Company

United Therapeutics Corp

Exchange

XNAS

Industry

Pharmaceutical Preparations · SEC standard industrial classification

SEC CIK

1082554

Sessions on record

131

Price source

End of day · delayed

Computed

1 Oct, 10:41 pm IST

OI Charts is not a registered investment adviser or broker-dealer. Prices, filings and open interest are public data and arithmetic on it, not a basis for any investment decision.